Skip to main content
INGN logo

Inogen, Inc.

INGNNASDAQHealthcareMedical Devices

$7.13Today:- (-)1Y −21.34%

As of Oct 27, 2026 close

Market cap
$192.83M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$5.05$9.13
Volume (live)
-
Avg. volume (3M)
355.81K

Inogen (INGN) Cash Flow Statement

In fiscal 2025 (fiscal year ended Dec 31, 2025), Inogen used $11.22M of cash in operating activities and spent $10.38M on capital expenditures. That left free cash flow of −$21.60M. It repurchased $821.00K of its own shares.

Inogen Cash Flow Statement Analysis

Values in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Inogen, Inc. (INGN) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Operating Activities
Net Income-22.75-35.89-102.45-83.77-6.33-5.8320.9551.8521.00
Depreciation & Amortization20.6621.0018.1523.5121.6318.5813.8311.3012.30
Deferred Income Tax-1.10-1.15-0.250.0014.44-0.082.87-11.607.95
Stock Based Compensation8.017.407.4312.2810.940.009.1312.799.64
Change in Working Capital-26.91-4.3914.27-44.72-20.07-0.03-27.89-25.65-10.64
Change in Accounts Receivable-14.62-5.1910.14-51.34-5.42-7.25-17.03-25.96-18.26
Change in Inventory-3.21-3.547.88-5.60-10.787.59-10.34-9.97-5.89
Change in Accounts Payable5.64-3.41-9.186.68-7.62-5.833.206.367.44
Change in Other Working Capital0.432.494.43-15.39-11.605.46-3.723.936.08
Other Operating Activities0.4317.7959.37-15.39-11.6024.3721.6921.2920.24
Net Cash from Operating Activities-11.225.91-3.23-37.5323.6337.0140.5959.9860.49
Investing Activities
Capital Expenditures-10.38-15.00-26.52-21.22-24.07-17.34-6.51-12.97-10.23
Acquisitions0.000.00-29.630.330.150.16-70.400.35-4.49
Purchases of Investments-29.83-32.66-26.8710.01-9.99-22.75-58.69-76.16-46.93
Sales/Maturities of Investments14.0035.5024.0010.0119.2614.5591.3563.4637.04
Other Investing Activities0.00-16.820.000.000.000.00-0.060.370.18
Net Cash from Investing Activities-26.21-13.98-59.32-10.88-14.65-25.64-44.06-24.97-24.43
Financing Activities
Common Stock Issued27.210.811.481.7415.652.420.0019.5014.00
Common Stock Repurchased-0.82-0.55-0.52-1.360.000.000.00-1.210.00
Other Financing Activities-4.00-0.55-0.52-1.36-0.65-0.354.9318.3014.00
Net Cash from Financing Activities24.180.270.960.3815.002.074.9318.3014.00
Summary
Effect of Forex Changes on Cash0.85-0.280.07-0.48-0.430.49-0.060.370.03
Net Change in Cash-12.40-8.08-61.52-48.5123.9913.931.4053.6850.10
Cash at Beginning of Period117.42125.49187.01235.52211.96198.04196.63142.9592.85
Cash at End of Period105.02117.42125.49187.01235.52211.96198.04196.63142.95
Free Cash Flow-21.60-9.09-29.75-58.75-0.4319.6734.0847.0050.27
Supplemental Disclosures
Income Taxes Paid-0.38-0.700.501.54-0.71---

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Inogen Cash Flow

What is Inogen's free cash flow?

Inogen had negative free cash flow of $21.60M in fiscal 2025 (fiscal year ended Dec 31, 2025), operating cash flow of −$11.22M minus $10.38M of capital expenditures.

How much does Inogen spend on capital expenditures?

Inogen spent $10.38M on capital expenditures in fiscal 2025, compared with $15.00M a year earlier.

Does Inogen pay dividends or buy back shares?

Yes. In fiscal 2025 Inogen returned $821.00K in share buybacks to shareholders, according to its cash flow statement.

What is free cash flow?

Free cash flow is operating cash flow minus capital expenditures. It is the cash a company has left for dividends, buybacks, debt repayment or acquisitions after funding its operations and investment. Full definition